Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| pericyte | 12 studies | 33% ± 12% | |
| fibroblast | 9 studies | 26% ± 10% | |
| cardiac muscle cell | 5 studies | 26% ± 9% | |
| type II pneumocyte | 5 studies | 23% ± 5% | |
| type I pneumocyte | 5 studies | 20% ± 3% | |
| mesothelial cell | 4 studies | 40% ± 16% | |
| adventitial cell | 3 studies | 22% ± 1% | |
| endothelial cell | 3 studies | 33% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| heart | 3 studies | 22% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 98% | 2141.34 | 638 / 653 | 81% | 6.09 | 492 / 605 |
| lung | 100% | 6669.94 | 578 / 578 | 63% | 4.45 | 731 / 1155 |
| stomach | 97% | 2784.61 | 348 / 359 | 40% | 1.37 | 113 / 286 |
| prostate | 87% | 2871.01 | 212 / 245 | 50% | 1.30 | 249 / 502 |
| bladder | 100% | 7752.05 | 21 / 21 | 25% | 1.05 | 125 / 504 |
| esophagus | 89% | 3108.53 | 1291 / 1445 | 31% | 0.89 | 56 / 183 |
| ovary | 98% | 3319.24 | 177 / 180 | 20% | 0.58 | 84 / 430 |
| intestine | 90% | 1974.33 | 871 / 966 | 25% | 0.73 | 134 / 527 |
| uterus | 99% | 3393.99 | 169 / 170 | 15% | 0.60 | 71 / 459 |
| breast | 86% | 2024.21 | 396 / 459 | 25% | 0.54 | 285 / 1118 |
| liver | 55% | 664.67 | 124 / 226 | 49% | 2.77 | 198 / 406 |
| pancreas | 28% | 249.91 | 93 / 328 | 75% | 2.60 | 133 / 178 |
| heart | 99% | 6402.85 | 850 / 861 | 0% | 0 | 0 / 0 |
| adipose | 97% | 3909.82 | 1172 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 95% | 6.12 | 76 / 80 |
| skin | 70% | 1458.05 | 1267 / 1809 | 21% | 0.97 | 100 / 472 |
| blood vessel | 79% | 1652.06 | 1048 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 54% | 658.72 | 431 / 803 | 0% | 0 | 0 / 0 |
| brain | 11% | 97.14 | 292 / 2642 | 32% | 0.59 | 226 / 705 |
| kidney | 13% | 171.99 | 12 / 89 | 9% | 0.17 | 84 / 901 |
| adrenal gland | 10% | 87.26 | 25 / 258 | 9% | 1.91 | 20 / 230 |
| spleen | 14% | 118.60 | 34 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 10% | 154.78 | 97 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 7% | 0.24 | 3 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.04 | 1 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO_0007166 | Biological process | cell surface receptor signaling pathway |
| GO_0016607 | Cellular component | nuclear speck |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0004930 | Molecular function | G protein-coupled receptor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ADGRD1 |
| Protein name | Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) Adhesion G protein-coupled receptor D1 |
| Synonyms | GPR133 PGR25 |
| Description | FUNCTION: Orphan receptor. Signals via G(s)-alpha family of G-proteins . Has protumorigenic function especially in glioblastoma . . |
| Accessions | ENST00000446583.6 ENST00000542091.5 A0A087WYZ5 Q6QNK2 ENST00000335486.10 F5H7I3 ENST00000261654.10 [Q6QNK2-1] ENST00000543617.2 [Q6QNK2-3] H0Y2U9 ENST00000535015.5 [Q6QNK2-4] |
